What are the recommended drugs and their dosages for the emergency treatment of a cobra bite?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Treatment of Cobra Bite: Drugs and Dosages

The definitive treatment for cobra envenomation is Anti-Snake Venom (ASV) administered intravenously at an initial dose of 10 vials, which should be given as soon as possible after the bite to prevent progression of neurotoxic symptoms including respiratory paralysis. 1, 2

Anti-Snake Venom (ASV) Administration

Initial Dosing

  • Administer 10 vials of ASV intravenously as the initial dose 1, 2
  • This single-dose approach offers practical advantages without increasing adverse reaction risk compared to lower initial doses 1
  • For cobra bites specifically, some cases may require substantially higher doses (up to 80-100 ml of polyvalent antivenom) if neurotoxic signs develop 3

Administration Protocol

  • Perform hypersensitivity testing before administration 2
  • Administer intravenously only—ASV is effective only via IV route 4
  • Have epinephrine readily available for anaphylactic reactions:
    • Adults: 0.3-0.5 mg intramuscularly in the anterolateral thigh 2
    • Children: 0.01 mg/kg (maximum 0.3 mg) intramuscularly 2
  • Diphenhydramine should be immediately available during ASV administration 4

Repeat Dosing

  • Additional vials may be required based on clinical response 5, 6
  • King cobra bites specifically may require "huge doses" for severe envenomation—one documented case required repeated large doses for clinical reversal 5
  • Most patients (25%) in documented series received 10 vials (1 dose), though some required more 6

Supportive Medications

Airway Management Preparation

  • Ensure immediate availability of intubation equipment and ventilatory support—cobra venom causes neurotoxic paralysis requiring mechanical ventilation in approximately 40% of cases 6
  • Ventilatory support may be needed for 4.5 to 7 days in severe cases 3

Adjunctive Medications

  • Broad-spectrum antibiotics should be administered to prevent secondary infection 4
  • Tetanus toxoid if immunization status is not current 4

Critical Management Points

Immediate Actions

  • Remove all rings and constricting objects from the bitten extremity immediately to prevent damage from progressive swelling 2
  • Immobilize the affected extremity as part of supportive care 1

Contraindicated Interventions

  • Do NOT apply tourniquets, ice, suction devices, or electric shock—these are ineffective and potentially harmful 1, 2
  • Do NOT perform incision and suction unless by experienced personnel within 5 minutes AND transport will exceed 30 minutes 4
  • Cryotherapy is absolutely contraindicated 4

Important Clinical Considerations

Timing is critical: Antivenom effectiveness is inversely proportional to the time elapsed between bite and administration 7. Once paralysis is established, antivenom provides minimal benefit, and treatment becomes primarily supportive with prolonged ventilation 3.

Neuromuscular blockade: Cobra venom produces a non-depolarizing neuromuscular block that responds poorly to prostigmine/neostigmine 3. This underscores the importance of early ASV administration before paralysis onset.

Hospital preparedness: Facilities in areas with endemic venomous snakes should perform hazard vulnerability assessments to determine appropriate ASV stocking levels 2.

References

Guideline

Anti-Snake Venom Dosage and Management for Common Krait Bite

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anti-Snake Venom Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical manifestations of Cape cobra (Naja nivea) bites. A report of 2 cases.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1985

Research

Evaluation and treatment of poisonous snakebites.

American family physician, 1994

Research

A king cobra bite in New York City.

Toxicon : official journal of the International Society on Toxinology, 1989

Research

Observations on the bite of the Mozambique spitting cobra (Naja mossambica mossambica).

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.